Brief: Revelation Biosciences Announces Results For Quarter Ended June 30

Revelation Biosciences

15/08/2022 22:34

Aug 15 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES INC. ANNOUNCES FINANCIAL RESULTS
FOR THE
THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND RECENT CORPORATE
PROGRESS
    * REVELATION BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.12
    * REVELATION BIOSCIENCES INC - ANTICIPATES PRECLINICAL DATA
FOR
REVTX-300 AS POTENTIAL THERAPY FOR TREATMENT OF CHRONIC ORGAN
DISEASE
    * REVELATION BIOSCIENCES INC - QTRLY $3.5 MILLION IN CASH
AND CASH
EQUIVALENTS

Source text for Eikon:  ID:nGNXlrFfB 
Further company coverage:  REVB.O 

 ((Reuters.Briefs@thomsonreuters.com;))